A leading New Zealand bariatric surgeon has warned that Wegovy, a newly available weight-loss drug that regulates your appetite and contains semaglutide, is not a standalone solution to obesity and ...

Why it's difficult for genetically obese people to permanently lose weight and your DNA creates biological barriers that make ...

MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...

Weight loss is known to improve health in obesity. A new study provides clues to how: by rejuvenating fat tissue and changing ...

Researchers have mapped human fat tissue at single-cell resolution, uncovering how obesity alters cellular stress, ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Weight loss injections will not be enough to make “lasting progress” in tackling the obesity epidemic, leading medical ...

Following a ketogenic diet, modified alternate-day fasting, or late time-restricted eating leads to more weight loss than ...

Weight loss jabs alone will not be enough to turn the tide on obesity – doctors - An estimated 1.5 million British people are ...

A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...